Acne characteristics in Latin American patients and the potential role of trifarotene
International Journal of Dermatology · 2023
DOI: 10.1111/ijd.16754 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Marco A D da Rocha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Acne Vulgaris, Dermatologic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Galderma International.
Abstract (Originalsprache)
Background
Individualization of treatment based on acne type and severity, location, disease burden, and patient preference is required to maximize efficacy, safety, and adherence to therapy. Latin American populations have unique attributes that must be considered as part of this process to improve clinical success and achieve patient goals. Acne is more common among patients with darker skin phototypes, in whom it is often associated with postinflammatory hyperpigmentation and scarring—the most important acne sequelae—potentially due to more frequent and more severe underlying inflammatory processes in this population.
Discussion
These data argue for an early and proactive approach to managing acne in these patients with agents that target the inflammatory processes that underlie acne and its sequelae. As a class, retinoids offer a spectrum of activity that may be useful in addressing the unique needs of Latin American populations.
Conclusion
Trifarotene, a novel, selective retinoid, has been evaluated in relevant patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Federal University of São Paulo, São Paulo, Brazil.
- ABC Medical Center, Hospital General de México, Mexico City, Mexico.
- Instituto de Investigaciones Médicas A. Lanari, University of Buenos Aires, Buenos Aires, Argentina.
- Celaskin Dermatology Clinic, Región Metropolitana, Chile.
- Galderma Research & Development, Lausanne, Switzerland.
- Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil.
ORCID-Profile: Marco A D da Rocha, Leonel Fierro-Arias
Förderung
- Galderma International
Zitieren
APA
da Rocha, M. A. D., Fierro-Arias, L., Cohen Sabban, E. N., Castillo, R. S., Chavda, R., & Almeida, L. M. (2023). Acne characteristics in Latin American patients and the potential role of trifarotene. International Journal of Dermatology. https://doi.org/10.1111/ijd.16754
Vancouver
da Rocha MAD, Fierro-Arias L, Cohen Sabban EN, Castillo RS, Chavda R, Almeida LM. Acne characteristics in Latin American patients and the potential role of trifarotene. International Journal of Dermatology. 2023. doi:10.1111/ijd.16754
BibTeX
@article{daRocha2023,
author = {da Rocha, Marco A D and Fierro-Arias, Leonel and Cohen Sabban, Emilia N and Castillo, Ricardo S and Chavda, Rajeev and Almeida, Luiz M},
title = {Acne characteristics in Latin American patients and the potential role of trifarotene},
journal = {International Journal of Dermatology},
year = {2023},
doi = {10.1111/ijd.16754}
}
EUVIMED